Abbott starts VOYAGER CE trial of Encantor heart valve system for aortic stenosis
ABT•Abbott started the VOYAGER CE trial of its investigational Encantor heart valve system, which will enroll up to 300 patients in Europe and Australia. The company plans a pivotal U.S. trial in the coming months.




